Acquiring Company
Jagsonpal Pharmaceuticals
Acquired Company
Aequitas Healthcare Private Limited
GurugramMumbaiBiotechnologyHealth CarePharmaceuticalpharmaceuticalsBiotechnologyHealth CarePharmaceuticalDescription
Jagsonpal Pharmaceuticals has announced its acquisition of an 85 percent stake in Aequitas Healthcare for Rs 20.8 crore. This strategic move marks Jagsonpal's entry into the hospital segment, which is rapidly growing in the pharmaceutical industry. The acquisition will be fully funded through internal accruals, with a swift completion expected by July 15, 2026.
Quick answer
Jagsonpal Pharmaceuticals is acquiring Aequitas Healthcare Private Limited, announced June 30, 2026. Jagsonpal Pharmaceuticals is based in Gurugram, Haryana, India.
- How much did Jagsonpal Pharmaceuticals pay for Aequitas Healthcare Private Limited?
- The deal value was not disclosed.
- What does Jagsonpal Pharmaceuticals do?
- Jagsonpal Pharmaceuticals is a prominent player in the pharmaceutical sector, focusing on various healthcare solutions.
- Where are Jagsonpal Pharmaceuticals and Aequitas Healthcare Private Limited based?
- Jagsonpal Pharmaceuticals is based in Gurugram, Haryana, India. Aequitas Healthcare Private Limited is based in Mumbai, Maharashtra, India.
- Who are the decision-makers at Jagsonpal Pharmaceuticals?
- Fundz holds 1 contact at Jagsonpal Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and pharmaceuticals
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Hanmi Pharmaceutical completes Aptose acquisition (June 30, 2026)
- GSK to acquire Nuvalent for $10.6 billion, $11B (June 9, 2026)
- GNI Group to acquire Ayumi Pharmaceutical Holdings (June 7, 2026)
Who to call at Jagsonpal Pharmaceuticals, and when
When Jagsonpal Pharmaceuticals changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Jagsonpal Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jagsonpal Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jagsonpal Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jagsonpal Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Aequitas Healthcare Private Limited?
Aequitas Healthcare Private Limited was acquired by Jagsonpal Pharmaceuticals, based in Gurugram. The deal was reported on June 30, 2026. Jagsonpal Pharmaceuticals is a prominent player in the pharmaceutical sector, focusing on various healthcare solutions. The company has recently ventured into the hospital segment through strategic acquisitions. Jagsonpal Pharmaceuticals is privately held and operates in Biotechnology.
When did Jagsonpal Pharmaceuticals acquire Aequitas Healthcare Private Limited?
Jagsonpal Pharmaceuticals's acquisition of Aequitas Healthcare Private Limited was reported on June 30, 2026. Jagsonpal Pharmaceuticals has announced its acquisition of an 85 percent stake in Aequitas Healthcare for Rs 20.8 crore. This strategic move marks Jagsonpal's entry into the hospital segment, which is rapidly growing in the pharmaceutical industry. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Aequitas Healthcare Private Limited do?
Founded in 2017, Aequitas Healthcare has built relationships with several leading hospital chains across India. The company reported FY26 revenue of approximately Rs 53 crore. It is privately held, operating in Biotechnology, and is based in Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.